title: Hemodialysis cost in Tehran, Iran.
abstract: The purpose of this study was to assess the health service cost of hemodialysis (HD) delivered at hospitals in Iran as a developing country with a well-defined program of renal replacement therapy. A cost analysis was performed from the viewpoint of the 2 hospitals, with 3 shifts and full chairs, on current practice for dialysis maintenance. Cost and patient data were collected in 2006 and from April 1 to May 31, 2007, respectively. A total of 22,464 HD sessions were performed and 247 patients were studied during the study period. The reference year for the value of USD for different mentioned costs was 2006. Health care sector costs associated with each HD session were estimated at US$78.87. Most of the total maintenance expenditure was made up of medical supplies (36.19%), with dialyzers as the major cost driver. Staff salaries represented 17% of the cost and fixed direct capital costs accounted for 21.4%. Of the family members, 32.4% accompanied their patients. The mean cost for transportation of patients and accompanied person was US$3.15 +/- 2.83 and US$1.5 +/- 0.29, respectively. These findings are important in the light of limited available resources coupled with the increasing prevalence of kidney failure. A major attempt should also be made to increase peritoneal dialysis coverage as in some centers we cannot keep all chairs full, especially in some vast areas. It is highly recommended to place initial focus on strategies and treatments that slow disease progression, to postpone renal replacement therapy to save resources.
authors.affiliation: Department of Nephrology, Tehran University, Tehran, Iran. mmahdavi@sina.tums.ac.ir
authors.forename: Mitra
authors.initials: M
authors.lastname: Mahdavi-Mazdeh
authors.forename: Mozafar
authors.initials: M
authors.lastname: Zamani
authors.forename: Mahnaz
authors.initials: M
authors.lastname: Zamyadi
authors.forename: Hamid
authors.initials: H
authors.lastname: Rajolani
authors.forename: Keyvan
authors.initials: K
authors.lastname: Tajbakhsh
authors.forename: Alireza
authors.initials: A
authors.lastname: Heidary Rouchi
authors.forename: Mahammad
authors.initials: M
authors.lastname: Aghighi
authors.forename: Azita
authors.initials: A
authors.lastname: Mahdavi
mesh_terms: D003906:Developing Countries; D016527:Drug Costs / Q000706:statistics & numerical data; D017048:Health Care Costs; D005102:Health Expenditures / Q000706:statistics & numerical data; D006801:Humans; D015994:Incidence; D007492:Iran / Q000453:epidemiology; D007676:Kidney Failure, Chronic / Q000191:economics* / Q000453:epidemiology / Q000628:therapy*; D009017:Morbidity; D015995:Prevalence; D006435:Renal Dialysis / Q000191:economics* / Q000706:statistics & numerical data; D012456:Salaries and Fringe Benefits / Q000706:statistics & numerical data